Crinetics Pharmaceuticals Inc Stock Performance
as on October 17, 2025 at 8:37 pm IST
Day's Low
Day's High
$41.07$42.8
0.46%
Downside
3.73%
Upside
52 Week's Low
52 Week's High
$24.1$62.5341.59%
Downside
51.55%
Upside
Crinetics Pharmaceuticals Inc share price movements today
- Previous Close
- $42.31
- Open
- $42.08
- Volume
- 120.4K
- Day's Low - High
- $41.07 - $42.8
- 52 Week Low - High
- $24.1 - $62.53
Crinetics Pharmaceuticals Inc Historical Returns
- 1 Month Return
- + 23.71 %
- 3 Month Return
- + 28.13 %
- 1 Year Return
- -28.19 %
- 3 Year Return
- + 133.5 %
- 5 Year Return
- + 148.15 %
Crinetics Pharmaceuticals Inc Stock Fundamentals & Key Indicators
Check Crinetics Pharmaceuticals Inc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.
Market Cap
$4.2B
EPS (TTM)
-4.7799
Dividend Yield
0.00%
Quarterly Earnings Growth YOY
0.00%
PE Ratio (TTM)
-16.31
Industry PE ratio
8.355964912280701
PEG Ratio
0EBITDA
-419.6M
Revenue (TTM)
1.4M
Profit Margin
0.00%
Return On Equity TTM
0.00%
Crinetics Pharmaceuticals Inc Stock Valuation
Track how Crinetics Pharmaceuticals Inc P/E has moved over time to understand its valuation trends.
Crinetics Pharmaceuticals Inc in the last 5 years
Lowest (-15.08x)
December 31, 2024
Today (-16.31x)
October 17, 2025
Industry (8.36x)
October 17, 2025
Highest (-5.61x)
December 31, 2022
Today’s Price to Earnings Ratio: -16.31x
Crinetics Pharmaceuticals Inc vs Peer Comparison
Compare market cap, revenue, PE, and other key metrics of Crinetics Pharmaceuticals Inc with its industry peers.
Company | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin % |
|---|---|---|---|---|---|
| BUY | $4.2B | 148.15% | -16.31 | 0.00% | |
| BUY | $61.6B | 230.86% | -505.15 | -12.96% | |
| NA | $35.8B | NA | NA | -3.89% | |
| BUY | $104.6B | 87.37% | 29.01 | 31.86% | |
| BUY | $61.1B | -5.1% | 14.53 | 31.37% |
Stock Returns calculator for Crinetics Pharmaceuticals Inc Stock including INR - Dollar returns
The Crinetics Pharmaceuticals Inc stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.
Investment Value
₹1,00,000
Crinetics Pharmaceuticals Inc investment value today
Current value as on today
₹74,941
Returns
Returns from Crinetics Pharmaceuticals Inc Stock
Dollar Returns*
₹4,914 (+4.91%)
Analyst Recommendation on Crinetics Pharmaceuticals Inc Stock
Based on 20 analysts
90.00%
Buy
10.00%
Hold
0.00%
Sell
Based on 20 analysts, 90% of analysts recommend a 'BUY' rating for Crinetics Pharmaceuticals Inc. Average target price of $80.27
Crinetics Pharmaceuticals Inc Share Price Target
Get share price movements and forecasts by analysts on Crinetics Pharmaceuticals Inc.
What analysts predicted
48.6%UPSIDE
Target Price
$80.27
Current Price
$41.26
Analyzed by
20 Analysts
Target
$80.27
Crinetics Pharmaceuticals Inc target price $80.27, a slight upside of 48.6% compared to current price of $41.26. According to 20 analysts rating.
Crinetics Pharmaceuticals Inc Stock’s Investor Sentiment and Interest
Investment in Crinetics Pharmaceuticals Inc Shares on INDmoney has grown by 333.33% over the past 30 days, indicating increased transactional activity.
Time period: to
Change:333.33% versus previous 30 day period
Search interest for Crinetics Pharmaceuticals Inc Stock has increased by 427% in the last 30 days, reflecting an upward trend in search activity.
Time period: to
Change:427% versus previous 30 day period
Crinetics Pharmaceuticals Inc Quarterly Profit & Loss
All numbers in Millions USD
Crinetics Pharmaceuticals Inc Annual Profit & Loss
All numbers in Millions USD
Crinetics Pharmaceuticals Inc Quarterly Cash Flow
All numbers in Millions USD
Crinetics Pharmaceuticals Inc Annual Cash Flow
All numbers in Millions USD
Crinetics Pharmaceuticals Inc News & Key Events
Today's Timeline - 26 September
Fri, 10:37 PM
-Crinetics Pharmaceuticals stock surges 27.35% after FDA approves Palsonify for acromegaly treatment.
Insights on Crinetics Pharmaceuticals Inc
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
POSITIVE IMPACTRevenue Rich
Revenue is up for the last 2 quarters, 361.0K → 1.03M (in $), with an average increase of 65.0% per quarter
NO EFFECTAgainst Peers
In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 62.1% return, outperforming this stock by 90.3%
- NO EFFECT
Against Peers
In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 146.6% return, outperforming this stock by 13.1%
NEGATIVE IMPACTProfit Down
Netprofit is down for the last 12 quarters, -40.39M → -115.63M (in $), with an average decrease of 10.2% per quarter
- NEGATIVE IMPACT
Price Dip
In the last 7 days, CRNX stock has moved down by -5.8%
About Crinetics Pharmaceuticals Inc
| Organisation | Crinetics Pharmaceuticals Inc |
| Headquarters | 6055 Lusk Boulevard, San Diego, CA, United States, 92121 |
| Industry | Health Technology |
| CEO | Dr. R. Scott Struthers Ph.D. |
| E-voting on shares | Click here to vote |
Key Management of Crinetics Pharmaceuticals Inc
Name | Title |
|---|---|
Dr. Alan S. Krasner M.D. | Chief Endocrinologist |
Mr. Jeff E. Knight M.P.H. | Chief Operating Officer |
Dr. Stephen F. Betz Ph.D. | Co-Founder & Chief Scientific Officer |
Dr. Dana Pizzuti M.D. | Chief Medical & Development Officer |
Mr. Tobin C. Schilke | Chief Financial Officer |
Ms. Gayathri Diwakar | Senior Director of Investor Relations |
Ms. Garlan Adams J.D. | Chief Legal Officer & Corporate Secretary |
Ms. Adriana Cabre M.B.A. | Chief Human Resources Officer |
Mr. Kevin Capps | Head of Intellectual Property |
Dr. R. Scott Struthers Ph.D. | Founder, President, CEO & Director |
FAQs
What is Crinetics Pharmaceuticals Inc share price today?
Crinetics Pharmaceuticals Inc share price today is $41.26 as on . Crinetics Pharmaceuticals Inc share today touched a day high of $42.8 and a low of $41.07.
What is the 52 week high and 52 week low for Crinetics Pharmaceuticals Inc share?
Crinetics Pharmaceuticals Inc share touched a 52 week high of $62.53 on and a 52 week low of $24.1 on . Crinetics Pharmaceuticals Inc stock price today i.e. is trending at $41.26,which is 34.02% down from its 52 week high and 71.20% up from its 52 week low.
What is Crinetics Pharmaceuticals Inc's market capitalisation today?
Crinetics Pharmaceuticals Inc market capitalisation is $0.00T as on .
How to invest in Crinetics Pharmaceuticals Inc Stock (CRNX) from India?
- Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
- Step 2: Search for Crinetics Pharmaceuticals Inc on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Crinetics Pharmaceuticals Inc Shares that will get you 0.0364 shares as per Crinetics Pharmaceuticals Inc share price of $41.26 per share as on October 17, 2025 at 8:37 pm IST.
What is the minimum amount required to buy Crinetics Pharmaceuticals Inc Stock (CRNX) from India?
Indian investors can start investing in Crinetics Pharmaceuticals Inc (CRNX) shares with as little as ₹88.054 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹880.54 in Crinetics Pharmaceuticals Inc stock (as per the Rupee-Dollar exchange rate as on ).
Based on Crinetics Pharmaceuticals Inc share’s latest price of $41.26 as on October 17, 2025 at 8:37 pm IST, you will get 0.2424 shares of Crinetics Pharmaceuticals Inc. Learn more about
fractional shares .
What are the returns that Crinetics Pharmaceuticals Inc has given to Indian investors in the last 5 years?
Crinetics Pharmaceuticals Inc stock has given 148.15% share price returns and 21.02% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?